Emerald Advisers, LLC Seagen Inc. Transaction History

Emerald Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$191.51 - $216.16 $454,070 - $512,515	2,371 Added 159.34%	3,859 $818,000
Q2 2023 Jul 25, 2023	SELL	$187.64 - $206.25 $3,940 - $4,331	-21 Reduced 1.39%	1,488 $286,000
Q1 2023 May 04, 2023	SELL	$127.59 - $203.08 $310,554 - $494,296	-2,434 Reduced 61.73%	1,509 $305,000
Q4 2022 Feb 03, 2023	SELL	$117.37 - $139.17 $7,746 - $9,185	-66 Reduced 1.65%	3,943 $506,000
Q3 2022 Oct 25, 2022	BUY	$135.27 - $180.11 $542,297 - $722,060	4,009 New	4,009 $549,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.